It has been suggested that MS may be associated with a direct effect of ATRA on adhesion molecules, a consequence of the prolonged survival, a high WBC (>10 × 109/L) at presentation, and the presence of bcr3 PML/RARA fusion transcripts (13). The gene discussed is PML; the disease is myeloid sarcoma.